Literature DB >> 35610497

Induction of enucleation in primary and immortalized erythroid cells.

Svetlana Soboleva1, Kenichi Miharada2,3.   

Abstract

Enucleation is a crucial event during the erythropoiesis, implicating drastic morphologic and transcriptomic/proteomic changes. While many genes deletion lead to failed or impaired enucleation have been identified, directly triggering the erythroid maturation, particularly enucleation, is still challenging. Inducing enucleation at the desired timing is necessary to develop efficient methods to generate mature, fully functional red blood cells in vitro for future transfusion therapies. However, there are considerable differences between primary erythroid cells and cultured cell sources, particularly pluripotent stem cell-derived erythroid cells and immortalized erythroid cell lines. For instance, the difference in the proliferative status between those cell types could be a critical factor, as cell cycle exit is closely connected to the terminal maturation of primary. In this review, we will discuss previous findings on the enucleation machinery and current challengings to trigger the enucleation of infinite erythroid cell sources.
© 2022. Japanese Society of Hematology.

Entities:  

Keywords:  Cytoskeleton; Enucleation; HDAC; Immortalized human erythroid cell lines; Red blood cell

Mesh:

Year:  2022        PMID: 35610497     DOI: 10.1007/s12185-022-03386-w

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.319


  73 in total

1.  Red blood cell proteomics update: is there more to discover?

Authors:  Angelo D'Alessandro; Monika Dzieciatkowska; Travis Nemkov; Kirk C Hansen
Journal:  Blood Transfus       Date:  2017-03       Impact factor: 3.443

2.  Studies on the mechanism of denucleation of the erythroblast.

Authors:  M Awai; S Okada; J Takebayashi; T Kubo; M Inoue; S Seno
Journal:  Acta Haematol       Date:  1968-04       Impact factor: 2.195

3.  Phosphatidylserine-dependent engulfment by macrophages of nuclei from erythroid precursor cells.

Authors:  Hideyuki Yoshida; Kohki Kawane; Masato Koike; Yoshimi Mori; Yasuo Uchiyama; Shigekazu Nagata
Journal:  Nature       Date:  2005-09-29       Impact factor: 49.962

Review 4.  Ex-vivo expansion of red blood cells: how real for transfusion in humans?

Authors:  Anna Rita Migliaccio; Elena Masselli; Lilian Varricchio; Carolyn Whitsett
Journal:  Blood Rev       Date:  2011-12-15       Impact factor: 8.250

5.  Cyclin D3 coordinates the cell cycle during differentiation to regulate erythrocyte size and number.

Authors:  Vijay G Sankaran; Leif S Ludwig; Ewa Sicinska; Jian Xu; Daniel E Bauer; Jennifer C Eng; Heide Christine Patterson; Ryan A Metcalf; Yasodha Natkunam; Stuart H Orkin; Piotr Sicinski; Eric S Lander; Harvey F Lodish
Journal:  Genes Dev       Date:  2012-08-28       Impact factor: 11.361

6.  Caspase-3 is involved in the signalling in erythroid differentiation by targeting late progenitors.

Authors:  Daniela Boehm; Christelle Mazurier; Marie-Catherine Giarratana; Dhouha Darghouth; Anne-Marie Faussat; Laurence Harmand; Luc Douay
Journal:  PLoS One       Date:  2013-05-02       Impact factor: 3.240

7.  The mechanism of denucleation in circulating erythroblasts.

Authors:  C F Simpson; J M Kling
Journal:  J Cell Biol       Date:  1967-10       Impact factor: 10.539

8.  Caspase activation is required for terminal erythroid differentiation.

Authors:  Y Zermati; C Garrido; S Amsellem; S Fishelson; D Bouscary; F Valensi; B Varet; E Solary; O Hermine
Journal:  J Exp Med       Date:  2001-01-15       Impact factor: 14.307

Review 9.  Squeezing for Life - Properties of Red Blood Cell Deformability.

Authors:  Rick Huisjes; Anna Bogdanova; Wouter W van Solinge; Raymond M Schiffelers; Lars Kaestner; Richard van Wijk
Journal:  Front Physiol       Date:  2018-06-01       Impact factor: 4.566

10.  Revised Estimates for the Number of Human and Bacteria Cells in the Body.

Authors:  Ron Sender; Shai Fuchs; Ron Milo
Journal:  PLoS Biol       Date:  2016-08-19       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.